Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells
Open Access
- 3 September 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (9) , e0226056
Abstract
The androgen receptor (AR) is activated in patients with castration resistant prostate cancer (CRPC) despite low circulating levels of androgen, suggesting that intracellular signaling pathways and non-androgenic factors may contribute to AR activation. Many G-protein coupled receptors (GPCR) and their ligands are also activated in these cells indicating that they may play a role in development of Prostate Cancer (PCa) and CRPC. Although a cross talk has been suggested between the two pathways, yet, the identity of GPCRs which may play a role in androgen signaling, is not established yet. By using blast analysis of 826 GPCRs, we identified a GPCR, GPCR 205, which exhibited maximum similarity with the ligand binding domain of the AR. We demonstrate that adhesion GPCR 205, also known as GPR56, can be activated by androgens to stimulate the Rho signaling pathway, a pathway that plays an important role in prostate tumor cell metastasis. Testosterone stimulation of GPR56 also activates the cAMP/ Protein kinase A (PKA) pathway, that is necessary for AR signaling. Knocking down the expression of GPR56 using siRNA, disrupts nuclear translocation of AR and transcription of prototypic AR target genes such as PSA. GPR56 expression is higher in all twenty-five prostate tumor patient’s samples tested and cells expressing GPR56 exhibit increased proliferation. These findings provide new insights about androgen signaling and identify GPR56 as a possible therapeutic target in advanced prostate cancer patients.Keywords
All Related Versions
Funding Information
- Department of Biotechnology(DBT), India (BT/Bio-CARe/01/668/2011-12 (2014-2018))
This publication has 52 references indexed in Scilit:
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1Cancer Cell, 2011
- GPR56 Regulates VEGF Production and Angiogenesis during Melanoma ProgressionCancer Research, 2011
- G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and laminationProceedings of the National Academy of Sciences, 2011
- GPR56 is essential for testis development and male fertility in miceDevelopmental Dynamics, 2010
- GPR56 Plays varying roles in endogenous cancer progressionClinical & Experimental Metastasis, 2010
- Regulation of cAMP Responses by the G12/13 Pathway Converges on Adenylyl Cyclase VIIJournal of Biological Chemistry, 2008
- Targeting the androgen receptor pathway in prostate cancerCurrent Opinion in Pharmacology, 2008
- GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasisProceedings of the National Academy of Sciences, 2006
- Seven-transmembrane receptorsNature Reviews Molecular Cell Biology, 2002
- Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the ProstateJournal of Urology, 2002